M3, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,646 JPY | -0.51% |
|
-12.61% | -29.43% |
| Apr. 29 | M3's Attributable Profit Drops 7.7% in Fiscal 2024 | MT |
| Apr. 29 | Jefferies Adjusts M3’s Price Target to 1,800 Yen From 2,200 Yen, Keeps at Hold | MT |
| Sales 2024 | 239B 1.56B | Sales 2025 * | 261B 1.71B | Capitalization | 1,118B 7.31B |
|---|---|---|---|---|---|
| Net income 2024 | 45.27B 296M | Net income 2025 * | 49.26B 322M | EV / Sales 2024 | 6.07 x |
| Net cash position 2024 * | 137B 897M | Net cash position 2025 * | 164B 1.07B | EV / Sales 2025 * | 3.65 x |
| P/E ratio 2024 |
32
x | P/E ratio 2025 * |
22.7
x | Employees | 10,533 |
| Yield 2024 |
0.98% | Yield 2025 * |
1.4% | Free-Float | 60.21% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.51% | ||
| 1 week | -12.61% | ||
| Current month | -22.95% | ||
| 1 month | -24.28% | ||
| 3 months | -30.19% | ||
| 6 months | -27.82% | ||
| Current year | -29.43% |
1 week
1 618.00
1 926.00
1 month
1 618.002 205.00
Current year
1 618.002 527.50
1 year
1 618.003 388.00
3 years
1 618.008 945.00
5 years
1 618.0010 675.00
10 years
641.0010 675.00
| Managers | Title | Age | Since |
|---|---|---|---|
Akihiko Tomaru
CEO | Chief Executive Officer | 51 | - |
Itaru Tanimura
PSD | President | 59 | 00-09-28 |
Kazuyuki Izumiya
BRD | Director/Board Member | 52 | 09-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Itaru Tanimura
PSD | President | 59 | 00-09-28 |
Akinori Urae
BRD | Director/Board Member | 66 | 14-05-31 |
Ryoko Toyama
BRD | Director/Board Member | 59 | 09-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 8.65% | 5 M€ | -8.46% | ||
| 5.00% | 6 M€ | +3.37% | ||
| 1.71% | 19 M€ | +3.93% | ||
| 1.32% | 67,864 M€ | +15.20% | ||
| 1.14% | 60 M€ | +16.25% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 1,646 | -0.51% | 5,109,100 |
| 24-05-01 | 1,655 | -2.16% | 8,423,200 |
| 24-04-30 | 1,692 | -9.91% | 13,090,300 |
| 24-04-26 | 1,878 | -0.29% | 3,917,400 |
| 24-04-25 | 1,883 | -1.18% | 2,075,000 |
Delayed Quote Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotes
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
Sector
Internet Services
Calendar
2024-06-25
- Shareholders Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
1,646
JPY
Average target price
2,476
JPY
Spread / Average Target
+50.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.43% | 7.27B | |
| +23.77% | 429B | |
| +16.08% | 244B | |
| +11.37% | 143B | |
| +16.30% | 101B | |
| +21.14% | 86.69B | |
| +56.55% | 58.56B | |
| +15.57% | 46.74B | |
| +15.33% | 35.13B | |
| +9.34% | 27.67B |
- Stock Market
- Equities
- 2413 Stock
